Omeros CorporationOMERNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank36
3Y CAGR-26.9%
5Y CAGR-28.8%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-26.9%/yr
vs +1.8%/yr prior
5Y CAGR
-28.8%/yr
Consistent
Acceleration
-28.7pp
Decelerating
Percentile
P36
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2024 | 4.05% |
| 2023 | 1.91% |
| 2022 | -5.10% |
| 2021 | 10.37% |
| 2020 | -1.90% |
| 2019 | 22.07% |
| 2018 | 61.62% |
| 2017 | 9.66% |
| 2016 | 4.80% |
| 2015 | 0.90% |